<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04327492</url>
  </required_header>
  <id_info>
    <org_study_id>250-19</org_study_id>
    <nct_id>NCT04327492</nct_id>
  </id_info>
  <brief_title>Hemathologic and Imagiologic Predictors of Stroke During Carotid Endarterectomy With Regional Anesthesia</brief_title>
  <official_title>Clinical, Hematological, and Imagiologic Predictors of Postoperative Complications and Long Term Cardiovascular Events After Carotid Endarterectomy With Regional Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade do Porto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade do Porto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Establish and validate biomarkers which improve the predictive value of current risk
      stratification models for patients benefiting from carotid revascularization, outperform
      existing biomarkers, and reach clinical application standards.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The authors hypothesize FGF-23 and GDF-15 could predict cerebral ischemia, postoperative
      complications and long term major cardiovascular events, particularly in patients developing
      symptomatic neurologic ischemia after circulation shutdown.

      Establish and validate biomarkers which improve the predictive value of current risk
      stratification models for patients benefiting from carotid revascularization, outperform
      existing biomarkers, and reach clinical application standards.

      Clarify the pathophysiology of carotid endarterectomy-related stroke and the role of GDF-15,
      FGF-23, BNP and hs-troponin I and other biomarkers in the prognosis of symptomatic carotid
      stenosis.

      Imagiologic markers are to be included - intima-media; gray weale plaque classification,
      cerebral CT Peak wave velocity
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Stroke</measure>
    <time_frame>30 days, long-term</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clavien dindo&gt;3</measure>
    <time_frame>30 days, long-term</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>MACE</measure>
    <time_frame>30 days, long-term</time_frame>
    <description>AMI, stroke, Major adverse limb event, acute hear faillure hospitalization, all cause mortality</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">272</enrollment>
  <condition>Carotid Stenosis</condition>
  <condition>Carotid Endarterectomy</condition>
  <arm_group>
    <arm_group_label>Carotid endarterectomy</arm_group_label>
    <description>This study is a non-interventional prospective cohort study. The population corresponds to patients submitted to CEA under regional anesthesia. Consecutive patients from a tertiary referral center who undergo CEA for carotid artery stenosis (CS) will be prospectively recruited. The expected patient follow-up will be of 5 years.
The demographics will be recorded in a prospective, protected database. Blood samples will be collected in clot activator serum tubes at three timepoints: timepoint 1 - before surgery (until 15 days before surgery); timepoint 2 up to 48h postoperatively; timepoint</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Biomarker - FGF 23; troponin I; PCR - high sensitivity; BNP</intervention_name>
    <description>peak wave velocity; gray weale plaque classification</description>
    <arm_group_label>Carotid endarterectomy</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood sample. atherosclerotic plaque
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients selected and submited to carotid endarterectomy under regional anesthesia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - consecutive patients from a tertiary referral center who undergo CEA for carotid artery
        stenosis (CS) under regional anesthesia

        Exclusion Criteria:

          -  general anesthesia

          -  carotid stenting
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Joao R Neves, MD, MSC, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade do Porto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joao R Neves, MD, MSC; MPH</last_name>
    <phone>+351910486230</phone>
    <email>joaorochaneves@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculdade de Medicina da Universidade do Porto</name>
      <address>
        <city>Porto</city>
        <zip>4200-319</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <contact>
      <last_name>Departamento FMUP</last_name>
      <phone>(+351) 22 551 3600</phone>
      <email>fmup@med.up.pt</email>
    </contact>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2020</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade do Porto</investigator_affiliation>
    <investigator_full_name>Jo√£o Rocha Neves</investigator_full_name>
    <investigator_title>MD, MSC; MPH, FEBVS</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

